New conformationally locked bicyclic N,O-nucleoside analogues of antiviral drugs
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (3), 545-550
- https://doi.org/10.1016/j.bmcl.2004.11.048
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapyAIDS, 2002
- Diastereoselective synthesis of N,O-psiconucleosides via 1,3-dipolar cycloadditionsTetrahedron Letters, 2001
- Synthesis of Isoxazolidino Analogues of 2′,3′-DideoxynucleosidesNucleosides and Nucleotides, 1999
- Antiretroviral treatment in 1998The Lancet, 1998
- Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) studyThe Lancet, 1998
- A Novel Class of 4′-Aza Analogues of 2′,3′-Dideoxynucleosides as Potential Anti-HIV DrugsNucleosides and Nucleotides, 1997
- Model studies towards the synthesis of 4′-azaerythrofuranosyladenines as analogues of the antiviral drug 2′,3′-dideoxyadenosine (ddA) 1Journal of the Chemical Society, Perkin Transactions 1, 1997
- Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and ZalcitabineNew England Journal of Medicine, 1996
- Synthesis of 4′-aza analogues of 2′,3′-dideoxythymidine by 1,3-dipolar cycloadditions of nitrones to 1-N-vinyl-thymineTetrahedron Letters, 1996
- Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitroNature, 1993